Ionis Pharmaceuticals IONS
$ 36.05
1.29%
Quarterly report 2024-Q3
added 11-06-2024
Ionis Pharmaceuticals Financial Statements 2011-2024 | IONS
Annual Financial Statements Ionis Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.26 B | 5.23 B | 4.48 B | 8.39 B | 8.34 B | 7.4 B | 6.54 B | 5.06 B | 4.66 B | 8.06 B | 5.52 B | 1.48 B | 821 M |
Shares |
143 M | 142 M | 141 M | 140 M | 140 M | 132 M | 124 M | 121 M | 120 M | 118 M | 111 M | 101 M | 99.7 M |
Historical Prices |
43.7 | 36.9 | 31.8 | 60.1 | 58.3 | 58 | 52.5 | 44.5 | 38.9 | 68.5 | 51.1 | 14.5 | 8.16 |
Net Income |
-9.26 M | -52.4 M | -28.6 M | -444 M | 294 M | 274 M | -5.97 M | -86.6 M | -88.3 M | -39 M | -60.6 M | -65.5 M | -84.8 M |
Revenue |
325 M | 152 M | 810 M | 729 M | 1.12 B | 600 M | 508 M | 347 M | 284 M | 214 M | 147 M | 102 M | 99.1 M |
Cost of Revenue |
9.13 M | 14.1 M | 10.8 M | 11.9 M | 4.38 M | 1.82 M | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 1.12 B | 598 M | 133 M | 2.3 M | -38.6 M | -27.6 M | -36.7 M | -56.4 M | 99.1 M |
Operating Income |
-6.12 M | -208 M | -30.2 M | -172 M | 366 M | -61.4 M | 31 M | -20.2 M | -75.8 M | -47.7 M | -51.7 M | -68.9 M | -71.1 M |
Interest Expense |
12.7 M | 8.12 M | 9.35 M | 9.51 M | 12.4 M | 44.8 M | 44.8 M | 38.8 M | 36.7 M | 22.2 M | 19.4 M | 21.2 M | 16.7 M |
EBITDA |
4.17 M | -194 M | -14.7 M | -159 M | 382 M | -48.8 M | 32.9 M | -37.3 M | -65.5 M | -38.3 M | -41.9 M | -58.2 M | -59.3 M |
Operating Expenses |
- | - | - | - | 752 M | 659 M | 483 M | 393 M | 359 M | 262 M | 199 M | 171 M | 170 M |
General and Administrative Expenses |
233 M | 150 M | 186 M | 354 M | 287 M | 245 M | 108 M | 48.6 M | 37.2 M | 20.1 M | 14.9 M | 12.5 M | - |
All numbers in USD currency
Quarterly Income Statement Ionis Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
149 M | 146 M | 146 M | 144 M | 143 M | 143 M | 143 M | 142 M | 142 M | 142 M | 142 M | 141 M | 141 M | 141 M | 141 M | 140 M | 140 M | 139 M | 139 M | 141 M | 141 M | 140 M | 139 M | 138 M | 137 M | 129 M | 125 M | 125 M | 124 M | 124 M | 123 M | 121 M | 121 M | 121 M | 121 M | 120 M | 120 M | 120 M | 119 M | 118 M | 118 M | 118 M | 117 M | 116 M | 115 M | 109 M | 102 M | 101 M | 101 M | 100 M | 100 M | 100 M | 99.7 M | 99.6 M | 99.6 M |
Net Income |
-140 M | -66.3 M | -143 M | - | -147 M | -85.3 M | -124 M | - | -47 M | -105 M | -65.2 M | 225 M | -82.5 M | -80.9 M | -89.9 M | -355 M | -24.5 M | -25.6 M | -39.6 M | 184 M | 26.2 M | -876 K | 84.4 M | 320 M | -4.56 M | -40.4 M | -1.42 M | -2.92 M | -2.61 M | -3.08 M | 8.96 M | 25.9 M | 7.35 M | -56.9 M | -62.9 M | -71.4 M | -35.8 M | 35.6 M | -16.7 M | 31.1 M | -26.7 M | -12.1 M | -31.3 M | -24.3 M | -36.4 M | -11.8 M | -1.67 M | -2.64 M | -37.6 M | -1.21 M | -24 M | -20 M | -26.9 M | -17.9 M | -20 M |
Revenue |
134 M | 225 M | 119 M | - | 144 M | 188 M | 131 M | - | 160 M | 134 M | 142 M | 440 M | 133 M | 126 M | 112 M | 290 M | 160 M | 146 M | 133 M | 494 M | 168 M | 164 M | 297 M | 192 M | 145 M | 118 M | 144 M | 168 M | 118 M | 112 M | 116 M | 160 M | 111 M | 38.5 M | 36.9 M | 51.6 M | 49.1 M | 120 M | 62.6 M | 84.9 M | 44.1 M | 57.1 M | 28.2 M | 42.2 M | 23.6 M | 38.1 M | 43.4 M | 19.9 M | 11.6 M | 47.3 M | 23.2 M | 32.4 M | 20.7 M | 24.8 M | 21.1 M |
Cost of Revenue |
1.07 M | 4.16 M | 2.15 M | - | 2.19 M | 2.54 M | 1.34 M | - | 1.52 M | 4.74 M | 4.17 M | - | 3.08 M | 2.96 M | 2.58 M | - | 3.09 M | 3.01 M | 2.55 M | - | 967 K | 1.36 M | 1.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-149 M | -66.1 M | -150 M | - | -143 M | -90.2 M | -114 M | - | -59.2 M | -85.5 M | -57.5 M | 221 M | -85.8 M | -73 M | -92 M | -22.7 M | -36.5 M | -51.8 M | -61.1 M | 261 M | 2.52 M | -18.8 M | 122 M | 10.8 M | -18.6 M | -50.3 M | -3.3 M | -6.2 M | 11.3 M | 6.45 M | 19.5 M | 41.2 M | 16.1 M | -48.9 M | -54.7 M | -62.9 M | -48.1 M | 44.6 M | -9.33 M | 10.1 M | -21.5 M | -6.65 M | -29.7 M | -19.9 M | -25.5 M | -7.93 M | 1.62 M | -26.1 M | -28 M | 3.7 M | -18.5 M | -18.6 M | -22.3 M | -14.1 M | -16.1 M |
Interest Expense |
4.16 M | 4.49 M | 4.15 M | - | 4.2 M | 2.29 M | 1.61 M | - | 2.14 M | 2.13 M | 2.12 M | - | 2.34 M | 2.36 M | 2.41 M | - | 2.43 M | 2.44 M | 2.21 M | - | 12 M | 11.8 M | 11.6 M | - | 11.3 M | 11.1 M | 10.9 M | - | 10.8 M | 11.8 M | 11.4 M | - | 9.75 M | 9.62 M | 9.49 M | - | 9.23 M | 9.13 M | 9.02 M | - | 5 M | 4.96 M | 4.94 M | - | 4.87 M | 4.81 M | 4.8 M | - | 5.94 M | 5.22 M | 5.18 M | - | 4.77 M | 3.44 M | 3.42 M |
EBITDA |
- | - | -147 M | - | - | - | -112 M | - | -47.9 M | -78 M | -53.8 M | 221 M | -74.2 M | -65 M | -88.1 M | -22.7 M | -26.8 M | -45.4 M | -57.9 M | 261 M | 11.9 M | -12.6 M | 125 M | 10.8 M | -10.9 M | -45.4 M | -938 K | -6.2 M | 17.4 M | 10.4 M | 21.5 M | 41.2 M | 21.7 M | -45.2 M | -52.8 M | -62.9 M | -42.9 M | 48.1 M | -7.76 M | 10.1 M | -16.7 M | -3.51 M | -28.1 M | -19.9 M | -20.5 M | -4.55 M | 3.33 M | -26.1 M | -28 M | 3.7 M | -18.5 M | -18.6 M | -22.3 M | -14.1 M | -16.1 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 181 M | 164 M | 168 M | 148 M | 174 M | 107 M | 106 M | 96.3 M | 119 M | 94.8 M | 87.4 M | 91.5 M | 115 M | 97.3 M | 75.8 M | 71.9 M | 74.8 M | 65.6 M | 63.7 M | 57.8 M | 62.1 M | 49.1 M | 46 M | 41.7 M | 46 M | 39.6 M | 43.6 M | 41.7 M | 51 M | 43 M | 38.9 M | 37.3 M |
General and Administrative Expenses |
61.6 M | 65.1 M | 52.6 M | - | 70 M | 46.1 M | 45.5 M | - | 34.4 M | 33.8 M | 34.1 M | - | 31.1 M | 56.5 M | 61.2 M | - | 68.4 M | 72 M | 75 M | - | 60 M | 75.1 M | 68.2 M | - | 68.7 M | 66.2 M | 43.7 M | - | 26.8 M | 22.3 M | 13.7 M | - | 10.2 M | 9.82 M | 10.6 M | - | 8.75 M | 7.78 M | 7.47 M | - | 4.47 M | 4.46 M | 4.38 M | - | 3.43 M | 3.39 M | 3.42 M | - | 3.1 M | 3.21 M | 2.98 M | - | 3.1 M | 2.87 M | 3.01 M |
All numbers in USD currency